Pharmacists in Harwich, MA Accepting Medicare
5 Pharmacists found. Showing 1 - 5
 Maureen Flynn Lynch Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 111 Route 137, Harwich, MA 02645 Phone: 508-432-5001 |
 Justin Morgan Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 111 Route 137, Harwich, MA 02645 Phone: 508-432-5001 |
Dr. Justin Moazzami, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 148 Route 137, Harwich, MA 02645 Phone: 508-432-2018 |
Derek Cannistraro Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 111 Route 137, Harwich, MA 02645 Phone: 508-432-5001 |
Ian Cooper, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 148 Route 137, Harwich, MA 02645 Phone: 508-432-2018 |
News Archive
Encision reports financial results for third-quarter of fiscal year 2010
Encision Inc., a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, reported its financial results for its third quarter of fiscal year 2010.
NanoBio to highlight prophylactic NE HSV-2 vaccine candidate at The Keystone Symposia Conference
NanoBio Corporation today announced that the company will present data at The Keystone Symposia Conference, The Modes of Action of Vaccine Adjuvants, in Seattle on October 12, 2014.
Young men with HIV infection have coronary atherosclerotic plaques: MGH study
A Massachusetts General Hospital (MGH) study has found that relatively young men with longstanding HIV infection and minimal cardiac risk factors had significantly more coronary atherosclerotic plaques - some involving serious arterial blockage - than did uninfected men with similar cardiovascular risk.
Smokers are misinformed about safety and efficacy of nicotine replacement therapy
Nearly half of all smokers in the United States attempt to quit at least once per year, yet the majority of these efforts fail. One factor contributing to the low annual rate of successful cessation is that the majority of quit attempts are made without evidence-based treatment such as nicotine replacement therapy.
Acceleron recieves $1.5 million MDA grant for ACE-031 clinical study in Duchenne Muscular Dystrophy
Acceleron Pharma, a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced it has been awarded a $1.5 million grant from the Muscular Dystrophy Association to support clinical studies of ACE-031 in Duchenne Muscular Dystrophy, a disabling neuromuscular disease in which patients experience a progressive loss of muscle mass and strength.
› Verified 6 days ago
Dentists
Clinical Social Workers
Counselors
Pharmacists
Occupational Therapists
Psychologists